Epidermal Growth Factor Receptor Inhibitor Database


Experimental Information
  
Enzymatic Activity
Molecule Id EGIN0000005
PMID 12384534
  Assay Used Substrate inhibition assay with EGFR prepared from the human vulval squamous carcinoma cell line A431, MTT assay was used to measure cell growth
  Experimently ValidatedYes
  EGFR (IC50)  33 nM
  HER2 (IC50)  3700 ± 10000 nM
  HER4 (IC50)  -
  Mutant L858R (IC50)  -
  Mutant T790M (IC50)  -
  Double Mutant (IC50)  -
  Average ERBB2 and ERBB1 (IC50) -
  Inhibition EGFR (%) -
  Inhibitory Concentration -
  Inhibition HER2 (%) -
  Inhibitory Concentration -
  Ki (EGFR)-
  Ki (HER2)-
  Ki (HER4)-
  Kd (EGFR)-
  Kd (L858R)-
  Kd (T790M)-
  Kd (L858R/T790M)-
  Kd (Other mutation)-
  Note ZD1839 is a potent EGFR-TKI in vitro. It is a competitive inhibitor of ATP and therefore binds at the ATP site on EGFR, it demonstrates remarkable selectivity for EGFR compared with other RTKs that share sequence homology in the ATP binding domain.The paper describes the ZD1839 (Iressa)as an Orally Active Inhibitor of Epidermal Growth Factor Signaling with Potential for Cancer Therapy
  Extra 0.027 µM [ EGFR (baculovirus lysate) ]

'; echo "" ; echo "" ; echo "" ; #echo "" ; echo "" ; #echo "" ; echo "" ; #echo "" ; echo "" ; #echo "" ; echo "" ; #echo "" ; echo "" ; #echo "" ; echo "" ; #echo "" ; echo "" ; echo "" ; echo "" ; #echo "" ; echo ''; } if($j%2==0){ echo ''; echo "" ; echo "" ; echo "" ; #echo "" ; echo "" ; #echo "" ; echo "" ; #echo "" ; echo "" ; #echo "" ; echo "" ; #echo "" ; echo "" ; #echo "" ; echo "" ; #echo "" ; echo "" ; echo "" ; echo "" ; #echo "" ; echo ''; } $j++; } echo ''; echo ''; echo "" ; echo ''; mysql_free_result($result2); ?>
Cellular Activity
S.No. Cell Line Desp. IC50 IC80 ED50 GI50 GI90 EC50 Kd Inhibition (%) Inhibitory Conc.
" .$j."" .$row2['Cell_Line']."" .$row2['Cell_line_desc']."" .$row2['IC50_cell_assay']."" .$row2['IC50_SIGN']." ".$row2['IC50_CONVERTED']."" .$row2['IC80_cell_assay']."" .$row2['IC80_SIGN']." ".$row2['IC80_CONVERTED']."" .$row2['ED50']."" .$row2['ED50_CONVERTED']."" .$row2['GI50_cell_assay']."" .$row2['GI50_SIGN']." ".$row2['GI50_CONVERTED']."" .$row2['GI90_CELL_ASSAY']."" .$row2['GI90_CELL_ASSAY']."" .$row2['EC50_cell_assay']."" .$row2['EC50_SIGN']." ".$row2['EC50_CONVERTED']."" .$row2['KD_CELL_ASSAY']."" .$row2['KD_CELL_ASSAY_CONVERTED']."" .$row2['per_Inhibition_Cellular']."" .$row2['Inhibition_conc3']."" .$row2['Cell_lines_used']."
" .$j."" .$row2['Cell_Line']."" .$row2['Cell_line_desc']."" .$row2['IC50_cell_assay']."" .$row2['IC50_SIGN']." ".$row2['IC50_CONVERTED']."" .$row2['IC80_cell_assay']."" .$row2['IC80_SIGN']." ".$row2['IC80_CONVERTED']."" .$row2['ED50']."" .$row2['ED50_CONVERTED']."" .$row2['GI50_cell_assay']."" .$row2['GI50_SIGN']." ".$row2['GI50_CONVERTED']."" .$row2['GI90_CELL_ASSAY']."" .$row2['GI90_CELL_ASSAY']."" .$row2['EC50_cell_assay']."" .$row2['EC50_SIGN']." ".$row2['EC50_CONVERTED']."" .$row2['KD_CELL_ASSAY']."" .$row2['KD_CELL_ASSAY_CONVERTED']."" .$row2['per_Inhibition_Cellular']."" .$row2['Inhibition_conc3']."" .$row2['Cell_lines_used']."

Activity against Receptor
  EGFR Yes
  HER2Yes
  HER4-
  Wild typeYes
  Mutant-

Inhibitor Binding
  EGFR-
  HER2-
  HER4-